Ergo Science Corporation

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Ergo Science Corporation is developing the drug ERGOSET(R) tablets for the treatment of metabolic disorders.

Contact Details: 790 Turnpike Street North Andover MA 01845 United States of America Tel: 978 974 9474 Fax: Email: WWW: www.ergo.com/

Loading...

Recent Publications by Ergo Science Corporation:
Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster. Bromocriptine, a dopamine D2 agonist, inhibits seasonal fattening and...	17th June, 2000	Ergo Science Corporation, North Andover, Massachusetts, USA.	Chronobiol Int. 2000 Mar;17(2):155-72.
Chronic ventromedial hypothalamic infusion of norepinephrine and serotonin promotes insulin resistance and glucose intolerance. The ventromedial hypothalamus (VMH) is involved in the regulation of...	25th April, 2000	Ergo Science	Neuroendocrinology. 1999 Dec;70(6):460-5.
Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Hypothalamic neuropeptide Y (NPY) and corticotropin-releasing hormone...	25th April, 2000	Ergo Science Corporation, N. Andover, Mass., USA.	Neuroendocrinology. 2000 Jan;71(1):68-78.
Hyperinsulinemia increases norepinephrine metabolism in the ventromedial hypothalamus of rats. Numerous studies have implicated increased ventromedial hypothalamic (VMH)...	4th March, 2000	Ergo Science Corp., North Andover, MA 01845, USA.	Neuroreport. 2000 Feb 7;11(2):383-7.

Ergo Science Corporation Patents:
US Patent No.	Title
5905083	Method of treating rheumatoid arthritis
5554623	Method for the long term reduction of body fat stores, insulin resistance, hypersinsulinemia and hyperglycemia in vertebrates
5565454	Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
5585347	Methods for the determination and adjustment of prolactin daily rhythms
5626860	Method for regulating metabolism with dopamine beta hydroxylase inhibitors
→View more Ergo Science Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 161 times since April 2007, the link to the organisation's website has been followed 36 times

Recent Search Terms used to find this page: www.ergo.com | Ergo Science Corporation | .

Search for more companies in North Andover

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ergo Science Corporation

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.